CARMIL2 and neoplasm: Since CD28 co-signalling is essential to activate naive T cells and to induce Teff responses, EBV+ SMT in the context of CARMIL2-deficiency might evade anti-tumour immunity and indicate a particular importance of CD28 co-signalling in controlling this tumour entity23.